- Home
- YOU vs AMRX Comparison
YOU vs AMRX Comparison
Compare YOU & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YOU
- AMRX
- Stock Information
- Founded
- YOU 2010
- AMRX 2002
- Country
- YOU United States
- AMRX United States
- Employees
- YOU N/A
- AMRX N/A
- Industry
- YOU Computer Software: Prepackaged Software
- AMRX Biotechnology: Pharmaceutical Preparations
- Sector
- YOU Technology
- AMRX Health Care
- Exchange
- YOU Nasdaq
- AMRX Nasdaq
- Market Cap
- YOU 2.2B
- AMRX 2.4B
- IPO Year
- YOU 2021
- AMRX N/A
- Fundamental
- Price
- YOU $24.00
- AMRX $7.85
- Analyst Decision
- YOU Buy
- AMRX Strong Buy
- Analyst Count
- YOU 5
- AMRX 5
- Target Price
- YOU $34.20
- AMRX $10.00
- AVG Volume (30 Days)
- YOU 1.6M
- AMRX 1.0M
- Earning Date
- YOU 02-26-2025
- AMRX 02-28-2025
- Dividend Yield
- YOU 3.28%
- AMRX N/A
- EPS Growth
- YOU 2686.35
- AMRX N/A
- EPS
- YOU 0.86
- AMRX N/A
- Revenue
- YOU $735,183,000.00
- AMRX $2,680,420,000.00
- Revenue This Year
- YOU $26.16
- AMRX $18.06
- Revenue Next Year
- YOU $14.26
- AMRX $3.82
- P/E Ratio
- YOU $26.06
- AMRX N/A
- Revenue Growth
- YOU 28.78
- AMRX 12.32
- 52 Week Low
- YOU $16.05
- AMRX $5.01
- 52 Week High
- YOU $38.88
- AMRX $9.48
- Technical
- Relative Strength Index (RSI)
- YOU 47.32
- AMRX 43.68
- Support Level
- YOU $21.67
- AMRX $7.66
- Resistance Level
- YOU $24.52
- AMRX $7.95
- Average True Range (ATR)
- YOU 0.84
- AMRX 0.21
- MACD
- YOU 0.08
- AMRX -0.03
- Stochastic Oscillator
- YOU 68.21
- AMRX 37.80
About YOU Clear Secure Inc.
Clear Secure Inc is an identity company making experiences safer and easier digitally and physically. It is involved in the creation of a frictionless travel experience while enhancing security. Its secure identity platform uses biometrics to automate the identity verification process through lanes in airports which helps to make the travel experience safe and easy.
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.